Patent · US Active

Crystalline form I of imatinib mesylate

US8592440B2 · kind B2 · utility

0Cited by
1References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJul 15, 2011
Grant dateNov 26, 2013
Priority date—
Expiry dateJul 15, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Crystalline forms of imatinib mesylate (F, G, H, I and K) and their respective characterizations are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.